Advanced glycation end‐products are a risk for muscle weakness in Japanese patients with type 1 diabetes. Issue 3 (23rd November 2016)

• Record Type: Journal Article
• Authors: Mori, Hiroyasu; Kuroda, Akio; Araki, Michiko; Suzuki, Reiko; Taniguchi, Satoshi; Tamaki, Motoyuki; Akehi, Yuko; Matsuhisa, Munehide
• Is Part Of: Journal of diabetes investigation. Volume 8:Issue 3(2017)
• Page Start: 377
• Page End: 382
• Publication Date: 2016-11-23
• Subjects: Advanced glycation end‐products -- Sarcopenia -- Type 1 diabetes; Diabetes -- Periodicals; Diabetes -- Research -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462005
• DOI: 10.1111/jdi.12582
• Languages: English
• ISSNs: 2040-1116

Abstract

Abstract: Accumulation of advanced glycation end‐products (AGEs) is thought to contribute to muscle weakness in a diabetic animal model. Skin autofluorescence is a proposed marker for accumulation of AGEs in the skin. We aimed to investigate the relationship between AGEs accumulation, sarcopenia and muscle function of Japanese patients with type 1 diabetes. A total of 36 patients with type 1 diabetes participated in the present cross‐sectional study. Sarcopenia parameters (skeletal muscle mass index and knee extension strength) were compared with subcutaneous AGEs accumulation using skin autofluorescence. The prevalence of sarcopenia and impaired knee extension strength was 16.6% (men 0.0%, women 22.2%) and 47.2% (men 22.2%, women 55.6%), respectively. Knee extension strength was negatively correlated with skin autofluorescence ( r ² = 0.14, P < 0.05), but not with skeletal muscle mass index. In conclusion, the AGEs accumulation might be one of the reasons of impaired lower limb muscle function in Japanese patients with type 1 diabetes. Abstract : The purpose of this study is to investigate the relationship between AGE accumulations, sarcopenia and muscle function of patients with type 1 diabetes. We found that impaired muscle function in lower limb was highly observed in type 1 diabetes, and was associated with accumulation of AGE.